Seongho Ryu
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 11
- Immunology 11
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 4
- T-cell and B-cell Immunology 3
- Co-authors
- Hyejin Choi (8 shared papers)Vivek Mittal (8 shared papers)Dingcheng Gao (8 shared papers)Linda T. Vahdat (4 shared papers)Nasser Khaled Altorki (4 shared papers)Sharrell B. Lee (4 shared papers)Anna Durrans (3 shared papers)Fuhai Li (2 shared papers)
- Journals
- Cell Reports (3 papers)PLoS ONE (3 papers)Cells (3 papers)Vaccine (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- South KoreaUnited StatesThailand
In The Last Decade
Seongho Ryu
54 papers receiving 3.6k citations
Seongho Ryu's Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.2k
- Cancer Research 594
- Immunology 366
- Molecular Biology 1.1k
- Pharmacology 208
Countries citing papers authored by Seongho Ryu
This map shows the geographic impact of Seongho Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seongho Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seongho Ryu more than expected).
Fields of papers citing papers by Seongho Ryu
This network shows the impact of papers produced by Seongho Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seongho Ryu. The network helps show where Seongho Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Seongho Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance Hit paper breakdown → | 2015 | 1518 |
| 2 | 2012 | 257 | |
| 3 | 2002 | 245 | |
| 4 | 2015 | 145 | |
| 5 | 2013 | 133 | |
| 6 | 2013 | 117 | |
| 7 | 2020 | 103 | |
| 8 | 2001 | 97 | |
| 9 | 2016 | 89 | |
| 10 | 2019 | 86 | |
| 11 | 2020 | 85 | |
| 12 | 2019 | 71 | |
| 13 | 2015 | 69 | |
| 14 | 2019 | 51 | |
| 15 | 2020 | 47 | |
| 16 | 2020 | 43 | |
| 17 | 2020 | 42 | |
| 18 | 2012 | 37 | |
| 19 | 2022 | 35 | |
| 20 | 2018 | 30 |
About Seongho Ryu
Seongho Ryu is a scholar working on Cancer Research, Immunology, Molecular Biology, Oncology and Epidemiology, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (15 papers), MicroRNA in disease regulation (11 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers), Immune cells in cancer (4 papers), T-cell and B-cell Immunology (3 papers), Genomics and Phylogenetic Studies (3 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (594 citations), Immunology (366 citations), Molecular Biology (1.1k citations) and Pharmacology (208 citations). Seongho Ryu has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Hyejin Choi, Vivek Mittal, Dingcheng Gao, Linda T. Vahdat, Nasser Khaled Altorki, Sharrell B. Lee, Anna Durrans, Fuhai Li, Jianting Sheng and Tina El Rayes. Their work appears in journals such as Cell Reports, PLoS ONE, Cells, Vaccine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.